Saputo Bets on High-Protein Ingredients After the UK Sale

Saputo created a dedicated ingredients division on September 23, 2026, five weeks after agreeing to sell its UK dairy unit to Lactalis for £988 million. The Montreal dairy group, listed in Toronto as SAP, said the new unit will chase higher-value dairy ingredients and high-protein products while Steve Douglas, still running the British business, takes the new president and chief operating officer job.

The company has made whey and other dairy solids for decades. What changed is the org chart, and the cheque coming from France. Packaged cheddar in Britain is leaving. Protein is staying, and it now has its own boss.

Saputo Carves Ingredients Out of Packaged Dairy

In a Montreal statement, Saputo called the move an evolution of its company structure, meant to tighten commercial execution in ingredients, speed up a shared-services overhaul, and back further expansion of that business. It is creating a dedicated Ingredients Division because, it said, demand for higher-value dairy ingredients keeps growing around the world.

Douglas will run commercial work, plants, product development, and growth for the new unit. He also stays president and chief operating officer of Dairy Division (UK) until the Lactalis deal completes. That dual job is the tell: ingredients get a full operating seat now, before the British brands actually leave the group.

As Saputo continues to evolve its portfolio and invest in growth opportunities, it is important that our organizational structure evolves alongside our business. These changes are intended to increase organizational focus, strengthen accountability, and improve execution across key strategic priorities.

Carl Colizza, President and Chief Executive Officer, Saputo statement, September 23, 2026

Colizza added that the changes do not rewrite the strategy the company has already been talking about. They are meant to put more weight behind value-added dairy and high-protein ingredients, digital and AI tools, simpler processes, and what the company calls sustainable growth. The statement did not say the new unit will be reported as its own financial segment.

£988 Million for Cathedral City and Its Sister Brands

On August 14, 2026, Saputo said it had a definitive agreement with B.S.A. SAS (Lactalis) to sell Dairy Division (UK) at an enterprise value of about £988 million. Closing is expected by the end of the first quarter of calendar 2027, subject to customary conditions and regulatory approvals. Over the last four quarters the British unit generated about C$1.2 billion of revenue, about 7% of the group.

The sale covers five plants and the local brands Cathedral City, Wensleydale, Davidstow, Clover, and Country Life. Lactalis, which said that day it had reached a deal to acquire its UK Dairy Division, listed the same cheddar and butter names plus Utterly Butterly spreads, and said the business employs about 1,300 people.

The plants sit at Hawes in Yorkshire, Davidstow in Cornwall, Nuneaton in Warwickshire, Kirkby in Merseyside, and the Isle of Bute in Scotland. Lactalis said 94% of sales are in the UK and 6% go to Europe, Asia-Pacific, and North America. For its latest financial year, a different period from Saputo’s four-quarter figure, Lactalis put revenue at €800 million. Chairman Emmanuel Besnier called the purchase a key step in Lactalis’s UK growth and said it would make the group a leading supplier of cheddar and of butter and spreads there.

Colizza’s August line was blunter than the September org-chart language. He said the sale was a disciplined step to refine the global footprint and put more weight on platforms where Saputo already competes from strength, and that the proceeds should add financial flexibility for organic projects and deals.

SAPUTO’S 2026 PORTFOLIO MOVES

1. June 18, 2026: Completes the sale of an 80% stake in Dairy Division (Argentina) to Gloria Foods, taking proceeds of about $710 million ($508 million USD), or about $612 million after tax, and keeping 20%.
2. June 22, 2026: Agrees to sell its interest in the Danone Saputo Dairy Australia joint venture to Danone Asia Pte Ltd for about $253 million (AU$257 million), with closing expected in the second half of calendar 2026, subject to approval.
3. August 14, 2026: Agrees to sell Dairy Division (UK) to Lactalis at about £988 million, targeting a close by the end of the first quarter of calendar 2027.
4. September 23, 2026: Creates the Ingredients Division and names Douglas, Haig Poutchigian, and Dave Paradis to the new operating jobs.

The UK exit is the largest brand sale in that sequence, but it is not a one-off. Argentina’s majority stake is already gone. The Australian joint venture is under contract. Ingredients are what the remaining company wants more of, not another national cheddar brand.

The Waupun Plant Was the Tell

Colizza has been saying the quiet part on earnings calls for months. Ingredients are not a start-up inside Saputo. The company has sold dairy solids for decades. Demand, he said, is now moving faster, and a Wisconsin upgrade was the bet placed before this new division existed.

On the call after fiscal 2026 year-end results, he pointed to the Waupun, Wisconsin plant, where Saputo spent heavily to add higher fractions of whey protein concentrates and to move into edible and dry-blend lactose. In a later quarterly presentation he put that work at about $180 million, with systems now making WPC80 and WPC34 plus a new lactose dryer, and said the work is lifting WPC80 output by about 35%.

Those solids come off cheese. More mozzarella and cheddar in the US network means more whey to fractionate. The new division does not invent that loop. It gives it a single commercial owner instead of leaving protein as the leftover of a packaged-dairy P&L.

The payoff already showed up in the first quarter of fiscal 2027, which ended June 30, 2026. Colizza said all four sectors made more money than a year earlier, and he put “clear momentum in our ingredients platform” next to strong volumes as the reason.

THE PROTEIN NUMBERS BEHIND THE CHART

• Group sales: Continuing operations revenue was $4.421 billion, up $65 million, or 1.5%, helped by higher dairy-ingredient market prices and more high-protein ingredient volume.
• Earnings: Adjusted EBITDA was $427 million, up $30 million, or 7.6%, and the adjusted EBITDA margin rose to 9.7% from 9.1%.
• What moved it: Saputo said recent capacity work let it meet high-protein ingredient demand, and that higher market prices for those products were favourable.
• Waupun: About $180 million went into whey systems that now run WPC80, WPC34, and a lactose dryer, with WPC80 output up about 35%.

That is why the September announcement reads as a wager rather than a rename. The plants were already being pointed at protein. The new box on the chart is how head office says it wants that mix to keep rising after Britain leaves.

The money for whey also sits in the US, not under Canada’s supply-managed milk system, where output is still steered by butterfat quotas and whey is a cheese by-product. Building isolate capacity next to Wisconsin milk that can grow with the plant is the practical version of the ingredients story. A Montreal division name does not change where the dryers are.

Who Runs the New Unit While the UK Sale Closes?

Three jobs moved on September 23. Only one of them is the protein brief, and that one still has a British business hanging off it until regulators and closing conditions clear.

THE NEW OPERATING JOBS

Douglas is the hinge. If the UK close slips past the first quarter of 2027, the ingredients chief is still running Cathedral City. If it closes on time, he drops the British P&L and keeps the global solids book. Either way, commercial focus on whey, lactose, and high-protein dairy is no longer an add-on to a country division.

Paradis takes Canada, the home market, at the same moment the group is selling a 7% revenue slice abroad. His brief is execution with retailers and foodservice, not the new ingredients title. The Canadian dairy business stays a branded and private-label foods operation. Protein growth is being housed next to it, not inside it.

Whey Is Where the Cheese Business Pays Extra

High-protein dairy is the part of the category that is still growing on volume, not just price. Processors with cheese plants already have the raw whey. The fight is over who can dry it into WPC80, isolate, and specialty fractions that sports drinks, clinical nutrition, and fortified foods will pay for, instead of dumping it as a bulk powder.

Saputo is walking into a market already occupied by names that built ingredients businesses years ago. Glanbia, Arla Foods Ingredients, Fonterra, FrieslandCampina, Kerry, and Lactalis Ingredients sell the same class of solids into the same industrial buyers. Cheese remains the feedstock. A dedicated division is how a cheese-heavy group tries to sell the leftover stream like a product line, not a by-product.

WHAT THE NEW UNIT IS BEING ASKED TO DO

• Own the solids book: Give whey, lactose, and high-protein dairy one commercial and operating boss instead of scattering them across country divisions.
• Push mix, not just volume: Move more output into higher fractions such as WPC80, rather than leaving the stream in basic powders.
• Use the cheese network: Treat US and other cheese plants as the milk source for those fractions, which is why Waupun sits next to the cheesemaking belt.
• Sell beyond the home brands: Take those solids into industrial nutrition, beverages, and specialty foods, the customers Colizza has been describing as the faster-moving part of demand.

Colizza has already described a retreat on the British ingredients side. In the UK the company walked away from demineralised whey and galacto-oligosaccharide work after demand in those lines fell, and shifted toward simpler whey products. The dedicated division is not a rescue of that UK ingredients book. It is a bet that the US, and other remaining plants, can do the higher-fraction work Britain was not set up to scale.

Shared Services Get a Transformation Chief

Poutchigian’s new title is the other half of the September chart. Saputo created a chief enterprise transformation officer to pull business administration, operational finance, and information technology into one services model. The company said that should improve consistency and scale, cut duplicate process, and support automation and data-led decisions.

That job is not the protein wager. It is the cost of running fewer country fiefdoms after Argentina, Australia, and the UK have been cut back. Digital and AI tools sit on the same priority list as high-protein ingredients, but the September statement did not say which systems, which plants, or what spending sits behind that line.

Investors who already treated Saputo as a whey-capacity name, rather than a British cheddar owner, were looking at Waupun and WPC80 long before the new letterhead. The division makes that reading official. It does not, by itself, add a dryer.

The Cash Still Needs a Regulatory Stamp

Until the UK sale closes, the ingredients chief is still the UK dairy chief, and the £988 million is still on paper. Saputo has not said whether ingredients will get their own published numbers, which markets Douglas will staff first, or how it defines “higher-value” beyond high-protein dairy. Those answers were not in the September 23 release.

WHAT WE KNOW

• The jobs: Douglas, Poutchigian, and Paradis were named on September 23, 2026, with the remits above.
• The UK terms: Lactalis is buying the division at about £988 million, with five plants and the Cathedral City brand set, targeting a close by the end of the first quarter of 2027.
• The protein spend: About $180 million went into Waupun whey systems, and Q1 fiscal 2027 results already cited high-protein ingredient volumes and prices.

WHAT IS UNCONFIRMED

• Separate accounts: Saputo has not said the Ingredients Division will be a reported segment.
• Target markets: No country list, customer list, or capacity target was published with the new chart.
• The close: The UK sale still needs regulatory approval and the other closing conditions in the August 14 agreement.

Douglas holds both operating jobs until that close. The protein unit is live on the chart. The British brands are not gone yet, and the cash from Lactalis is not in the bank.